The Effects of Case Management in a Medicaid Managed Care Plan
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate whether or not case management by a social worker and nurse can decrease the number of emergency room visits, increase the number of primary care doctor visits, and increase quality of life of people in a Medicaid managed care plan.
| Condition | Intervention |
|---|---|
|
Neoplasms Heart Diseases Adrenal Cortex Diseases |
Behavioral: Case management |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Open Label Primary Purpose: Supportive Care |
| Official Title: | The Effects of Case Management in a Medicaid Managed Care Plan |
- The outcome measure for the number of emergency room visits will be calculated from the medical record counting the number of hospital emergency room visits; for access to primary physicians, the medical record will be reviewed as well.
- The outcomes for quality of life will be evaluated from the McGill Quality of Life Questionnaire.
| Estimated Enrollment: | 500 |
| Study Start Date: | May 2006 |
| Estimated Study Completion Date: | January 2008 |
This study will assign participants based on Zip Code to one of two conditions: control and experimental. In the control group, participants will receive telephonic assessments at baseline, three months, and six months. These assessments will be conducted by a member of the Medical Center’s Department of Geriatrics under the supervision of the Principal Investigator. Participants in the experimental group will receive medical case management provided by a nurse and social worker in the homecare setting including an in-home assessment. Assessments will be conducted at baseline, three months, and six months during routine homecare visits. Dependent variables being measured include: access to primary care physicians, emergent hospitalizations/admissions, articulation of advance directives, and quality of life. Data will be collected through the participants’ medical claims and records to analyze the number of emergent hospitalizations/admissions, documentation of advance directives, and number of visits to primary care physicians. To measure participants’ quality of life, the Depression Self-Rating Scale and the Clinical Anxiety Scale will be utilized. Data will be compared between and within the groups via statistical analyses. The researcher will conduct pre-post comparisons of utilization and other database-derived outcomes for both groups, comparing the 12 months prior to and up to 20 months following enrollment.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- participation in a Medicaid managed care plan
- resident of identified zip codes in Brooklyn, NY
- frequent hospitalizations and low frequency of primary doctor visits
Exclusion Criteria:
- residents outside the catchment area
- patients not being managed in a Medicaid managed care plan
Contacts and Locations| Contact: Russell E Hilliard, PhD, LCSW | 718-491-7214 | rhilliar@mjhs.org |
| Contact: Eliot Fishman, PhD | 718-491-7134 | efishman@mjhs.org |
| United States, New York | |
| Metropolitan Jewish Health System | Recruiting |
| Brooklyn, New York, United States, 11220 | |
| Sub-Investigator: Eliot Fishman, PhD | |
| Principal Investigator: | Barbara Paris, MD | Maimonides Medical Center |
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00385879 History of Changes |
| Other Study ID Numbers: | Health Plus at Home |
| Study First Received: | October 9, 2006 |
| Last Updated: | October 10, 2006 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Adrenal Cortex Diseases Neoplasms Heart Diseases |
Adrenal Gland Diseases Endocrine System Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 23, 2013